Real-world effectiveness and safety of camrelizumab plus platinum and taxane as first-line treatment for advanced esophageal squamous cell carcinoma

AiRuiKa (camrelizumab) - Elevar Therapeutics

https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal_2/print/presentation/5760

Zhihao Lu; Jun Zhao; Zhe Yang; Na Li; Junsheng Wang; Shuanghu Yuan; Yusheng Wang; Suyi Li; Fengming Ran; Yinghua Ji; Yanqiao Zhang; Chen Wang; Lixin Wan; Ming Wang; Liang Liang; XiaoFang Dai; Guanghui Cheng; Wei Li; Peng Zhen; Lin Shen

Jul 17, 2026